Search
for
Sort by
Research 151–180 of 1000+
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Age-associated inflammation inhibits epidermal stem cell function
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis
- Feminizing Adrenocortical Carcinoma Without Gynecomastia
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
- Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin
- Inorganic Nanozymes: Prospects for Disease Treatments and Detection Applications
- A Rare Case of Lower Back Swelling Diagnosed as Low- Grade Trichoblastic Carcinoma Following Excision: A Case Report
- Botulinum Toxin in the Treatment of Hair and Scalp Disorders: Current Evidence and Clinical Applications
- Hirsutism and virilization
- Ligand‐Independent Actions of the Vitamin D Receptor: More Questions Than Answers
- Melanocyte Chitosan/Gelatin Composite Fabrication with Human Outer Root Sheath-Derived Cells to Produce Pigment
- Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma
- Pseudoglucagonoma syndrome secondary to pancreatitis: A case report
- GSDMA deficiency impairs cutaneous squamous cell carcinoma growth
- ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
- Supplements That May Counteract Side Effects from Conventional Cancer Therapies
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- Responsive Microneedles as a New Platform for Precision Immunotherapy
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- TLRgeting Evasion of Immune Pathways in Glioblastoma